Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lymphoma, non-hodgkin
Phenotype C0019158|hepatitis
Sentences 2
PubMedID- 24060287 Bendamustine and rituximab for indolent b-cell non-hodgkin lymphoma in patients with compensated hepatitis c cirrhosis: a case series.
PubMedID- 21188204 In a recently published review of 160 chronic hepatitis c patients with non-hodgkin lymphoma, twenty-four (15%) of them developed significant liver toxicity during chemotherapy [14].

Page: 1